quantumcodex
@incandescencefg
The mainstream still lacks effective tools to identify who benefits most from specific therapies, particularly regarding viral persistence and pathogen reactivation. Our Long COVID and IACC communities urgently need precise solutions.
0 reply
0 recast
0 reaction